1. Home
  2. RAYA vs UBX Comparison

RAYA vs UBX Comparison

Compare RAYA & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAYA
  • UBX
  • Stock Information
  • Founded
  • RAYA 2019
  • UBX 2009
  • Country
  • RAYA China
  • UBX United States
  • Employees
  • RAYA N/A
  • UBX N/A
  • Industry
  • RAYA Metal Fabrications
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RAYA Consumer Discretionary
  • UBX Health Care
  • Exchange
  • RAYA Nasdaq
  • UBX Nasdaq
  • Market Cap
  • RAYA 35.3M
  • UBX 38.6M
  • IPO Year
  • RAYA 2022
  • UBX 2018
  • Fundamental
  • Price
  • RAYA $1.26
  • UBX $2.10
  • Analyst Decision
  • RAYA
  • UBX Strong Buy
  • Analyst Count
  • RAYA 0
  • UBX 2
  • Target Price
  • RAYA N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • RAYA 9.4K
  • UBX 364.5K
  • Earning Date
  • RAYA 01-01-0001
  • UBX 11-04-2024
  • Dividend Yield
  • RAYA N/A
  • UBX N/A
  • EPS Growth
  • RAYA N/A
  • UBX N/A
  • EPS
  • RAYA N/A
  • UBX N/A
  • Revenue
  • RAYA $22,816,585.00
  • UBX N/A
  • Revenue This Year
  • RAYA $64.53
  • UBX N/A
  • Revenue Next Year
  • RAYA $9.61
  • UBX $33.62
  • P/E Ratio
  • RAYA N/A
  • UBX N/A
  • Revenue Growth
  • RAYA N/A
  • UBX N/A
  • 52 Week Low
  • RAYA $0.50
  • UBX $0.94
  • 52 Week High
  • RAYA $1.78
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • RAYA 47.39
  • UBX 62.50
  • Support Level
  • RAYA $1.22
  • UBX $2.05
  • Resistance Level
  • RAYA $1.44
  • UBX $2.42
  • Average True Range (ATR)
  • RAYA 0.08
  • UBX 0.31
  • MACD
  • RAYA -0.01
  • UBX -0.01
  • Stochastic Oscillator
  • RAYA 37.93
  • UBX 41.67

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: